Skip to main content

Table 3 Association between HVS and MACE (Fine-Gray competing risk model)

From: Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus

 

Unadjusted Model

Model 1

Model 2

sHR (95%CI)

p-value

sHR (95%CI)

p-value

sHR (95%CI)

p-value

HVS < 1/3

1.0 (reference)

1.0 (reference)

1.0 (reference)

1/3 ≤ HVS < 2/3

1.58 (1.29—1.94)

 < 0.001

1.51 (1.22—1.86)

 < 0.001

1.44 (1.14—1.81)

0.002

HVS ≥ 2/3

2.13 (1.67—2.71)

 < 0.001

2.04 (1.58—2.62)

 < 0.001

1.91 (1.46—2.51)

 < 0.001

  1. Model 1: adjusted for time-weighted average HbA1c
  2. Model 2: adjusted for time-weighted average HbA1c and other factors (age, sex, cardiovascular disease history, body mass index, hemoglobin, albumin and C-reactive protein)
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us